Market Overview The anti-venom market is expanding as recombinant anti-venom development addresses supply shortages, moving beyond traditional equine and ovine plasma fractionation to engineered monoclonal antibodies, nanobodies, and oligoclonal cocktails that can be manufactured consistently without immunized animal dependency. These next-generation biologics promise to eliminate...